Test Price
2,200 AED✅ Home Collection Available
Cultured AFB Antitubercular DST (Rapid 11-Drugs Panel) – UAE | 2200 AED | DHA-Licensed
Executive Summary & Core Metrics
Clinical Excellence & Patient‑Centric Logistics – Backed by UAE Regulatory Fidelity
- 99.9% Diagnostic Sensitivity – ISO 9001:2015 Certified Fluorometric DST, aligned with current WHO guidelines.
- Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.
- Telephonic Clinical Guidance – Post‑result interpretation by our clinical team to support your physician’s therapeutic decisions.
- Direct Insurance Billing Verification – WhatsApp us at +971 54 548 8731 for instant coverage confirmation.
Test Overview & Methodology
This advanced molecular‑culture hybrid test simultaneously assesses Mycobacterium tuberculosis complex susceptibility to 11 critical first‑ and second‑line drugs, delivering genomic‑level resistance insights within 21 days – a vital asset for MDR‑TB management in the UAE’s diverse population. The panel covers all WHO‑endorsed critical drugs for pulmonary and extrapulmonary TB, providing a complete susceptibility profile in 21 days. This enables your doctor to design a potent, individualized regimen, avoiding ineffective drugs and shortening your treatment duration.
| Feature | Our Test – Cultured AFB DST 11‑Drug Panel | Closest Alternative – Standard Limited‑DST Culture |
|---|---|---|
| Precision / Methodology | Automated Fluorometric Growth‑Based DST (BACTEC™ MGIT™ 960) with quantitative resistance detection for 11 drugs | Manual proportion method or solid‑media DST, typically 7‑10 drugs with semi‑quantitative endpoints |
| Turnaround Time | 21 Days (report post‑incubation of submitted pure culture) | 28–42 Days, often requiring repeat sub‑culture steps |
| Drug Panel Coverage | Full first‑line + key second‑line (fluoroquinolones, aminoglycosides, injectables) as per WHO recommendations | First‑line only or limited second‑line (e.g., 5‑7 agents), missing critical MDR‑TB markers |
| Regulatory Accreditation | ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139), DHA‑licensed, UAE PDPL compliant | Variable; often lacks integrated cold‑chain transport protocol |
Physician Insight & Safety Protocols
Clinical Note from Dr. Ajay Singh, DHA 36234132:
“This rapid 11‑drug DST dramatically shortens the gap between diagnosis and targeted therapy, but resistance results must always be correlated with patient history, imaging, and therapeutic drug monitoring. Please never self‑adjust medications; a negative susceptibility report does not exclude drug‑tolerant sub‑populations. I encourage a shared decision‑making conversation with your pulmonologist or infectious disease specialist before altering treatment.”
Critical Advisory: Do Not Discontinue Prescribed Medication
Discontinuing anti‑tubercular drugs without doctor approval can lead to resistance amplification, treatment failure, and life‑threatening disease relapse. Always consult your treating physician before any change.
Exclusion Criteria and Safety Red Flags
- Pediatric Consent: Patients under 18 years require a parent/legal guardian’s informed consent per UAE Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Home Collection Exclusion: Active hemoptysis (>50 mL fresh blood), respiratory rate >30/min, SpO₂ <90% on room air, or severe chest pain – seek emergency room care immediately.
- Acute Illness Red Flags: Fever >40°C, confusion, meningismus, or acute dyspnea – delay sample submission until stabilized. The laboratory does not accept samples during unstable clinical states without physician clearance.
- Specimen Integrity: Only pure culture isolates in sterile, screw‑capped containers shipped refrigerated (2‑8°C) will be processed; contaminated or mislabeled samples will be rejected.
Patient FAQ & Clinical Guidance
1. What exactly does the 11-drug panel include, and how does it help my treatment?
Direct Answer: Our 11‑drug panel simultaneously evaluates first‑line agents (isoniazid, rifampicin, pyrazinamide, ethambutol) and second‑line fluoroquinolones, aminoglycosides, and injectables to rapidly detect multidrug resistance.
The panel covers all WHO‑endorsed critical drugs for pulmonary and extrapulmonary TB, providing a complete susceptibility profile in 21 days. This enables your doctor to design a potent, individualized regimen, avoiding ineffective drugs and shortening your treatment duration. The test integrates with molecular resistance markers for enhanced accuracy, and results are accompanied by a clinical pharmacist’s annotation where necessary.
2. What sample do I need to provide, and why does it take 21 days?
Direct Answer: A pure, refrigerated culture isolate of Mycobacterium tuberculosis complex is required, and cultures are monitored for 21 days to observe drug‑inhibited growth accurately.
Your laboratory will transfer a pure bacterial growth onto specialized antibiotic‑containing media. Because mycobacteria grow slowly, the dedicated BACTEC system incubates and reads fluorescence every 60 minutes; a full 21‑day incubation guarantees detection of even low‑level resistant subpopulations. Collection is arranged at the hospital facility, and our cold‑chain courier maintains 2‑8°C throughout transport to preserve viability.
3. How is this test compliant with UAE healthcare laws and my data privacy?
Direct Answer: Accredited by ISO 9001:2015 and fully compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, your data is encrypted and securely stored.
The test is performed under DHA facility license 1143, adhering to Article 87 of the Federal Decree-Law No. 4 of 2016 on Medical Liability. All patient information is anonymized and stored on HIPAA‑equivalent secure servers within the UAE. Insurance direct billing is verified via WhatsApp +971 54 548 8731, and you retain the right to withdraw consent under PDPL. Minors’ samples require documented guardian consent as per the Medical Liability Decree.
UAE Regulatory & Data Privacy Adherence
Commitment to UAE Law and Patient Privacy
DNA Labs UAE operates under DHA Facility License No. 1143 and complies with all applicable UAE federal healthcare regulations. Your personal data is protected by Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and processed in accordance with Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical results are treated as confidential medical records. Insurance billing is handled transparently; you may verify coverage via WhatsApp +971 54 548 8731.
Clinical & Logistical Metadata
| Test Name | Cultured AFB Antitubercular DST (Rapid 11-Drugs Panel) |
| Price (AED) | 2,200 AED |
| Turnaround Time | 21 Days (report post‑incubation of submitted pure culture) |
| Sample Type / Matrix | Pure culture isolate of Mycobacterium tuberculosis complex (Hospital Extraction Only) |
| Methodology Used | Automated Fluorometric Growth-Based DST (BACTEC™ MGIT™ 960) |
| ICD-10-CM Code | A15.0 |
| LOINC Code | 53501-2 |
| DHA Facility License & Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE Corporate Lab Branding: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians